| Year |
Citation |
Score |
| 2019 |
Tassone E, Bradaschia-Correa V, Xiong X, Sastre-Perona A, Josephson AM, Khodadadi-Jamayran A, Melamed J, Bu L, Kahler DJ, Ossowski L, Leucht P, Schober M, Wilson EL. KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone. Oncogene. PMID 31239516 DOI: 10.1038/S41388-019-0841-3 |
0.381 |
|
| 2018 |
Xiong X, Schober M, Tassone E, Khodadadi-Jamayran A, Sastre-Perona A, Zhou H, Tsirigos A, Shen S, Chang M, Melamed J, Ossowski L, Wilson EL. KLF4, A Gene Regulating Prostate Stem Cell Homeostasis, Is a Barrier to Malignant Progression and Predictor of Good Prognosis in Prostate Cancer. Cell Reports. 25: 3006-3020.e7. PMID 30540935 DOI: 10.1016/J.Celrep.2018.11.065 |
0.399 |
|
| 2011 |
Marzan CV, Kupumbati TS, Bertran SP, Samuels T, Leibovitch B, Mira-y-Lopez R, Ossowski L, Farias EF. Adipocyte derived paracrine mediators of mammary ductal morphogenesis controlled by retinoic acid receptors. Developmental Biology. 349: 125-36. PMID 20974122 DOI: 10.1016/J.Ydbio.2010.10.018 |
0.604 |
|
| 2010 |
Cohn E, Ossowski L, Bertran S, Marzan C, Farias EF. RARα1 control of mammary gland ductal morphogenesis and wnt1-tumorigenesis. Breast Cancer Research : Bcr. 12: R79. PMID 20923554 DOI: 10.1186/Bcr2724 |
0.597 |
|
| 2010 |
Ossowski L, Aguirre-Ghiso JA. Dormancy of metastatic melanoma. Pigment Cell & Melanoma Research. 23: 41-56. PMID 19843243 DOI: 10.1111/J.1755-148X.2009.00647.X |
0.376 |
|
| 2009 |
Chaurasia P, Mezei M, Zhou MM, Ossowski L. Computer aided identification of small molecules disrupting uPAR/alpha5beta1--integrin interaction: a new paradigm for metastasis prevention. Plos One. 4: e4617. PMID 19242538 DOI: 10.1371/Journal.Pone.0004617 |
0.434 |
|
| 2009 |
Estrada Y, Dong J, Ossowski L. Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation. Pigment Cell & Melanoma Research. 22: 66-76. PMID 18983537 DOI: 10.1111/J.1755-148X.2008.00520.X |
0.399 |
|
| 2009 |
Vocca I, Franco P, Alfano D, Votta G, Carriero MV, Estrada Y, Caputi M, Netti PA, Ossowski L, Stoppelli MP. Inhibition of migration and invasion of carcinoma cells by urokinase-derived antagonists of alphavbeta5 integrin activation. International Journal of Cancer. 124: 316-25. PMID 18844213 DOI: 10.1002/ijc.23933 |
0.356 |
|
| 2008 |
Wang LG, Johnson EM, Kinoshita Y, Babb JS, Buckley MT, Liebes LF, Melamed J, Liu XM, Kurek R, Ossowski L, Ferrari AC. Androgen receptor overexpression in prostate cancer linked to Pur alpha loss from a novel repressor complex. Cancer Research. 68: 2678-88. PMID 18413735 DOI: 10.1158/0008-5472.Can-07-6017 |
0.364 |
|
| 2006 |
Franco P, Vocca I, Carriero MV, Alfano D, Cito L, Longanesi-Cattani I, Grieco P, Ossowski L, Stoppelli MP. Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and alpha v beta 5 integrin. Journal of Cell Science. 119: 3424-34. PMID 16882693 DOI: 10.1242/Jcs.03067 |
0.349 |
|
| 2006 |
Chaurasia P, Aguirre-Ghiso JA, Liang OD, Gardsvoll H, Ploug M, Ossowski L. A region in urokinase plasminogen receptor domain III controlling a functional association with alpha5beta1 integrin and tumor growth. The Journal of Biological Chemistry. 281: 14852-63. PMID 16547007 DOI: 10.1074/Jbc.M512311200 |
0.469 |
|
| 2006 |
Mazzieri R, D'Alessio S, Kenmoe RK, Ossowski L, Blasi F. An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration. Molecular Biology of the Cell. 17: 367-78. PMID 16267271 DOI: 10.1091/Mbc.E05-07-0635 |
0.46 |
|
| 2004 |
Aguirre-Ghiso JA, Ossowski L, Rosenbaum SK. Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth. Cancer Research. 64: 7336-45. PMID 15492254 DOI: 10.1158/0008-5472.Can-04-0113 |
0.439 |
|
| 2004 |
Wang LG, Ossowski L, Ferrari AC. Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line. Oncogene. 23: 5175-84. PMID 15156193 DOI: 10.1038/Sj.Onc.1207654 |
0.393 |
|
| 2004 |
Aguirre-Ghiso JA, Estrada Y, Liu D, Ossowski L. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK)1 Urologic Oncology-Seminars and Original Investigations. 22: 82. DOI: 10.1016/J.Urolonc.2003.12.012 |
0.363 |
|
| 2003 |
Aguirre-Ghiso JA, Estrada Y, Liu D, Ossowski L. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Research. 63: 1684-95. PMID 12670923 |
0.405 |
|
| 2002 |
Liu D, Aguirre Ghiso J, Estrada Y, Ossowski L. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell. 1: 445-57. PMID 12124174 DOI: 10.1016/S1535-6108(02)00072-7 |
0.425 |
|
| 2001 |
Aguirre-Ghiso JA, Liu D, Mignatti A, Kovalski K, Ossowski L. Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Molecular Biology of the Cell. 12: 863-79. PMID 11294892 DOI: 10.1091/Mbc.12.4.863 |
0.446 |
|
| 2000 |
Ossowski L, Aguirre-Ghiso JA. Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. Current Opinion in Cell Biology. 12: 613-20. PMID 10978898 DOI: 10.1016/S0955-0674(00)00140-X |
0.471 |
|
| 1999 |
Aguirre Ghiso JA, Kovalski K, Ossowski L. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. The Journal of Cell Biology. 147: 89-104. PMID 10508858 DOI: 10.1083/Jcb.147.1.89 |
0.506 |
|
| 1999 |
Gao M, Ossowski L, Ferrari AC. Activation of Rb and decline in androgen receptor protein precede retinoic acid-induced apoptosis in androgen-dependent LNCaP cells and their androgen-independent derivative. Journal of Cellular Physiology. 179: 336-46. PMID 10228952 DOI: 10.1002/(Sici)1097-4652(199906)179:3<336::Aid-Jcp11>3.0.Co;2-Q |
0.413 |
|
| 1997 |
Kjøller L, Kanse SM, Kirkegaard T, Rodenburg KW, Rønne E, Goodman SL, Preissner KT, Ossowski L, Andreasen PA. Plasminogen activator inhibitor-1 represses integrin-and vitronectin- mediated cell migration independently of its function as an inhibitor of plasminogen activation Experimental Cell Research. 232: 420-429. PMID 9168821 DOI: 10.1006/Excr.1997.3540 |
0.315 |
|
| 1997 |
Yu W, Kim J, Ossowski L. Reduction in surface urokinase receptor forces malignant cells into a protracted state of dormancy. The Journal of Cell Biology. 137: 767-77. PMID 9151680 DOI: 10.1083/Jcb.137.3.767 |
0.514 |
|
| 1994 |
Busso N, Masur SK, Lazega D, Waxman S, Ossowski L. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. The Journal of Cell Biology. 126: 259-70. PMID 7517943 DOI: 10.1083/Jcb.126.1.259 |
0.401 |
|
| 1994 |
Kook YH, Adamski J, Zelent AZ, Ossowski L. The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy. The Embo Journal. 13: 3983-3991. DOI: 10.1002/J.1460-2075.1994.Tb06714.X |
0.463 |
|
| 1991 |
Ossowski L, Clunie G, Masucci MT, Blasi F. In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion. The Journal of Cell Biology. 115: 1107-12. PMID 1659573 DOI: 10.1083/Jcb.115.4.1107 |
0.47 |
|
| 1989 |
Ossowski L. In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase. The Journal of Cell Biology. 107: 2437-45. PMID 2848851 DOI: 10.1083/JCB.107.6.2437 |
0.32 |
|
| 1986 |
Mira-y-Lopez R, Joseph-Silverstein J, Rifkin DB, Ossowski L. Identification of a pituitary factor responsible for enhancement of plasminogen activator activity in breast tumor cells. Proceedings of the National Academy of Sciences of the United States of America. 83: 7780-4. PMID 3463998 DOI: 10.1073/PNAS.83.20.7780 |
0.33 |
|
| Show low-probability matches. |